Early HCV RNA values after interferon predict response

Digestive Diseases and Sciences

Volumn 43, Issue 10, 1998, Pages 2169-2172

  Wiley, Thelma E ^a   Briedi, Lama ^a   Lam, Nancy ^a   Layden, Thomas J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cirrhosis; HCV; Interferon

Indexed keywords

RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; DNA DETERMINATION; DRUG EFFECT; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; TREATMENT OUTCOME;

FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031733777     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026613116942     Document Type: Article

References (11)

1. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, et al: Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter, randomized, controlled study. N Engl J Med 321:1501-1506, 1989
2. Shindo M, DiBisceglie AM, Cheung L, Shih JWL, Cristiano K, Feinstone SM, Hoofnagle JH: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 115:700-704, 1991
3. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, et al: Significance of serum hepatitis C virus RNA levels in chronic hepatitis. Lancet 341:1501-1504, 1993
4. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, et al: Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19:1088-1094, 1994
5. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, et al: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056, 1995
6. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JYN: Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C. Journal of Medical Virology 46:109-115, 1995
7. Gretch D, Lee W, Corey L: Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol 30:2145-2149, 1992
8. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al: Typing hepatitis C virus by polymerase chain reaction with type specific primers: application to clinical surveys and tracing infections sources. J Gen Virol 73:673-679, 1992
9. Lam N, Neumann A, Gretch D, Wiley T, Perelson A, Layden T: Dose dependent acute clearance of hepatitis C genotype I virus with interferon alpha. Hepatology 26:226-231, 1997
10. Perelson AS, Neumann AU, Markowitz J, Leonard JM, Ho DD: HIV-I dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 271:1582-1586, 1996
11. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, et al: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122, 1995